Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet function in the myelodysplastic syndromes.

M Mittelman1, A Zeidman

  • 1Department of Medicine, Rabin Medical Center, Petah-Tikva, Israel. mittelman@sela.co.il

International Journal of Hematology
|April 4, 2000
PubMed
Summary

Platelet aggregation defects are common in myelodysplastic syndromes (MDS), affecting up to 75% of patients. While bleeding is uncommon, these platelet function abnormalities may correlate with bleeding severity and serve as prognostic markers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythropoiesis-stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower-risk myelodysplastic syndrome.

Journal of internal medicine·2016
Same author

Miscommunicating NOTA Can Be Costly to Living Donors.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Chronic Myelogenous Leukemia Associated with Extranodal B-Cell Lymphoma.

Leukemia & lymphoma·2016
Same author

Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England.

International journal of geriatric psychiatry·2009
Same author

[Internal medicine 2007--where do we stand? To expand or to reduce?].

Harefuah·2007
Same author

[Out-of-hospital resuscitation in Israel 2000].

Harefuah·2004

Area of Science:

  • Hematology
  • Stem Cell Biology

Background:

  • Bleeding in myelodysplastic syndromes (MDS) is typically linked to thrombocytopenia.
  • MDS, a stem cell disorder, may also involve platelet function (PF) abnormalities contributing to bleeding risks.

Purpose of the Study:

  • To investigate the prevalence and significance of platelet aggregation (PA) defects in MDS patients.
  • To explore the potential role of PF abnormalities as diagnostic and prognostic markers in MDS.

Main Methods:

  • A review and summary of existing studies on platelet aggregation in approximately 68 MDS patients.
  • Analysis of various platelet function tests, including aggregation responses to epinephrine, arachidonic acid, ADP, collagen, and ristocetin.

Main Results:

Related Experiment Videos

  • Platelet aggregation defects are prevalent in MDS, with reduced PA observed in about 75% of patients using epinephrine.
  • Significant percentages of patients showed decreased PA with arachidonic acid (54%), ADP (46%), collagen (43%), and ristocetin (22%).
  • A potential correlation between the extent of PA defects and the tendency/severity of bleeding was suggested.

    • Conclusions:

    • Platelet aggregation defects are common in MDS patients, irrespective of thrombocytopenia.
    • PF studies may offer value in diagnosing challenging MDS cases and serve as prognostic indicators.
    • Further large-scale studies are warranted to confirm the role and impact of PF abnormalities in MDS.